← Leaderboards
Paul Clark Blainey
Broad Institute, Inc.
$19,793,618
Attributed
$24,836,922
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2016–25$10M$7.5M$5M$2.5M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,836,922 · 10
By mechanism
RM1$7,893,143 · 2
U19$7,693,856 · 2
R01$4,792,449 · 1
DP2$2,745,000 · 1
R21$1,035,447 · 2
R61$414,047 · 1
Top collaborators
- Clotilde Lagier-Tourenne3 shared
- Michael Emmerson Ward3 shared
- Yonatan H Grad2 shared
- Nir Hacohen1 shared
Most similar at Broad Institute, Inc.
Same institution · by research overlap
- Catherine Ju-Ying Wu$43,266,044
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsGenomicsTechnologyAffectGenesScreeningLibrariesComplexBiologyPhenotypeSamplingBaseGenetic ScreeningGenome-WideNovel TherapeuticsRunningFunctional GenomicsDesignGrowthOpticsPharmacotherapyCostGenome Wide ScreenMicroscopy
Grant awards (24)
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases$1,621,934
RM1 · FY2025 · NS
Profiling and perturbing the inheritance of drug-induced metabolic states in cancer with Inheritance-Seq$206,955
R61 · FY2025 · CA · contact PI
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases$1,398,275
RM1 · FY2024 · NS
Profiling and perturbing the inheritance of drug-induced metabolic states in cancer with Inheritance-Seq$207,092
R61 · FY2024 · CA · contact PI
Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout$164,661
R21 · FY2024 · CA · contact PI
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases$2,072,934
RM1 · FY2023 · NS
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies$1,584,870
U19 · FY2023 · AI · contact PI
Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout$167,252
R21 · FY2023 · CA · contact PI
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies$1,687,630
U19 · FY2022 · AI · contact PI
Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout$207,784
R21 · FY2022 · CA · contact PI
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies$1,589,329
U19 · FY2021 · AI · contact PI
Center for Cell Circuits$2,800,000
RM1 · FY2020 · HG
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies$1,531,949
U19 · FY2020 · AI · contact PI
Arrayed single-cell readout of pooled genetic perturbation libraries$1,112,161
R01 · FY2020 · HG · contact PI
High-content optical pooled genome-wide screens of SARS-CoV-2 infection$357,840
R01 · FY2020 · HG · contact PI
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies$1,300,078
U19 · FY2019 · AI · contact PI
Arrayed single-cell readout of pooled genetic perturbation libraries$1,120,845
R01 · FY2019 · HG · contact PI
Arrayed single-cell readout of pooled genetic perturbation libraries$1,073,196
R01 · FY2018 · HG · contact PI
Live Cell Transcriptomics$2,745,000
DP2 · FY2017 · HL · contact PI
Arrayed single-cell readout of pooled genetic perturbation libraries$1,128,407
R01 · FY2017 · HG · contact PI
Microfluidic sample preparation for genomic sequencing of clinical pathogen isolates$274,500
R21 · FY2017 · AI · contact PI
Automated and sensitive genomic co-profiling for precision pharmacogenomics$131,490
K01 · FY2017 · AI · contact PI
Microfluidic sample preparation for genomic sequencing of clinical pathogen isolates$221,250
R21 · FY2016 · AI · contact PI
Automated and sensitive genomic co-profiling for precision pharmacogenomics$131,490
K01 · FY2016 · AI · contact PI